Jiang Yong, Wan Yuan-lian, Liu Yu-cun, Wang Xin, Pan Yi-sheng, Wu Tao, Wang Peng-yuan, Huang Shan-jun
Department of General Surgery, The First Hospital, Peking University, Beijing 100034, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Aug;14(8):582-5.
To evaluate the surgical outcomes for patients with locally recurrent rectal cancer (LRRC) and to analyze the prognostic factors.
Clinical data of 187 patients with LRRC undergoing surgery at the First Hospital of peking University from January 1985 to December 2009 were retrospectively reviewed.
Procedures performed included local resection(n=34), abdominoperineal resection (n=35), posterior pelvic exenteration (n=17), total pelvic exenteration(TPE, n=98), TPE with sacrectomy (n=2), and TPE with internal hemipelvectomy (n=1). The operation was R0 in 87 patients, R1 in 60, and R2 in 40. The degree of radical resection was associated with the initial surgery and the degree of pelvic fixation (P<0.05). The pelvic recurrence rate was 44.4%(64/144). The operative morbidity and mortality were 47.5%(89/187) and 2.7%(5/187), respectively. The overall 3- and 5-year survival rates were 42.2% and 30.7%, respectively. The degree of radical resection and lymph node metastasis were independent risk factors associated with prognosis. The 5-year survival rates of R0, R1 and R2 were 42.6%, 17.2% and 0, respectively(P<0.01). The 5-year survival rates of patients with and without lymph node metastasis were 5.6% and 40.5%(P<0.01) respectively.
Accurate evaluation of extent of pelvic fixation and achievement of R0 resection are critical to improve the surgical outcomes for LRRC.
评估局部复发性直肠癌(LRRC)患者的手术疗效并分析预后因素。
回顾性分析1985年1月至2009年12月在北京大学第一医院接受手术的187例LRRC患者的临床资料。
手术方式包括局部切除(n = 34)、腹会阴联合切除术(n = 35)、后盆腔脏器清除术(n = 17)、全盆腔脏器清除术(TPE,n = 98)、TPE联合骶骨切除术(n = 2)以及TPE联合半侧盆腔切除术(n = 1)。87例患者达到R0切除,60例为R1切除,40例为R2切除。根治性切除程度与初次手术及盆腔固定程度相关(P<0.05)。盆腔复发率为44.4%(64/144)。手术并发症发生率和死亡率分别为47.5%(89/187)和2.7%(5/187)。3年和5年总生存率分别为42.2%和30.7%。根治性切除程度和淋巴结转移是与预后相关的独立危险因素。R0、R1和R2切除患者的5年生存率分别为42.6%、17.2%和0(P<0.01)。有和无淋巴结转移患者的5年生存率分别为5.6%和40.5%(P<0.01)。
准确评估盆腔固定范围并实现R0切除对于改善LRRC患者的手术疗效至关重要。